Intrapleural Administration of HSV1716 to Treat Patients With Malignant Pleural Mesothelioma.

NCT01721018 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Pleural Mesothelioma

Interventions

BIOLOGICAL: HSV1716 Intra-pleural delivery

Sponsor

Virttu Biologics Limited